Filing Details
- Accession Number:
- 0001179110-20-001026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 17:24:52
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-04 17:24:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682323 | Charles Albright | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-31 | 17,977 | $0.00 | 26,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-03 | 5,549 | $26.54 | 20,553 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2020-01-31 | 17,977 | $0.00 | 17,977 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which vested in full on January 31, 2020.
- Such amount includes common stock received by the Reporting Person in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023, which was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 8, 2019.
- The sales reported in this Form 4 were effected pursuant to an durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represent the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 31, 2020. The sales do not represent a discretionary trade by the Reporting Person.
- The restricted stock unit award vested in full on January 31, 2020.
Billionaire Hedge Funds
